NE
NASDAQ · NEUP
Neuphoria Therapeutics Inc.
Healthcare · Medical - Pharmaceuticals
$3.81
Up+$0.07 (+1.86%)
Updated Aug 13, 2026, 9:43 PM
SID Score
3.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.4M
- P/E ratio
- -0.02
- Dividend yield
- 0.00%
- 52-week range
- $3.19 – $5.53
- Volume
- 33.77K
- Avg. volume
- 1.58M
Price performance
NEUP price history
1M range · 21 trading sessions · Daily adjusted prices
NEUP closed at $3.81 after 21 trading sessions, up 8.24% for the selected period.
- Last close
- $3.81
- Period change
- +8.24%
- Period low
- $3.30
- Period high
- $3.95
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 12, 2026 | $3.79 | $3.87 | $3.75 | $3.81 | 33.77K |
| Aug 11, 2026 | $3.81 | $3.86 | $3.80 | $3.81 | 30.36K |
| Aug 10, 2026 | $3.81 | $3.89 | $3.81 | $3.86 | 15.5K |
| Aug 7, 2026 | $3.88 | $3.98 | $3.82 | $3.82 | 9.55K |
| Aug 6, 2026 | $3.92 | $4.10 | $3.83 | $3.90 | 29.71K |
| Aug 5, 2026 | $3.89 | $3.99 | $3.84 | $3.95 | 40.9K |
| Aug 4, 2026 | $3.89 | $3.98 | $3.88 | $3.89 | 42K |
| Aug 3, 2026 | $3.86 | $4.05 | $3.75 | $3.93 | 57.87K |
| Jul 31, 2026 | $3.90 | $4.00 | $3.8715 | $3.88 | 37.28K |
| Jul 30, 2026 | $3.80 | $4.06 | $3.73 | $3.92 | 71.16K |
| Jul 29, 2026 | $3.85 | $3.92 | $3.77 | $3.80 | 81.18K |
| Jul 28, 2026 | $3.88 | $3.91 | $3.71 | $3.81 | 97.14K |
| Jul 27, 2026 | $3.73 | $4.0205 | $3.60 | $3.85 | 205.85K |
| Jul 24, 2026 | $3.86 | $3.90 | $3.54 | $3.64 | 392.79K |
| Jul 23, 2026 | $3.80 | $4.20 | $3.68 | $3.92 | 7.62M |
| Jul 22, 2026 | $3.39 | $3.42 | $3.28 | $3.33 | 47.41K |
| Jul 21, 2026 | $3.39 | $3.55 | $3.31 | $3.34 | 47.26K |
| Jul 20, 2026 | $3.40 | $3.485 | $3.30 | $3.30 | 71.08K |
| Jul 17, 2026 | $3.45 | $3.62 | $3.385 | $3.415 | 46.84K |
| Jul 16, 2026 | $3.49 | $3.65 | $3.49 | $3.53 | 16.27K |
| Jul 15, 2026 | $3.55 | $3.62 | $3.45 | $3.52 | 14.63K |
Latest NEUP news
The latest Smart Investors Daily articles mentioning NEUP.
Stock researchResearch & News · SEC Filings
Loading stock research…
